Tesaro v Myriad: Niraparib partners squared off in court as Tesaro tried to quash a contrary press release
When Tesaro released their data on the PARP drug niraparib a few days ago, the biotech was determined to make a case for a broad …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
